Suppr超能文献

液体复苏中胶体液与晶体液的比较:随机对照试验分析

Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials.

作者信息

Bisonni R S, Holtgrave D R, Lawler F, Marley D S

机构信息

Department of Family Medicine, University of Oklahoma Health Sciences Center, Oklahoma City 73190.

出版信息

J Fam Pract. 1991 Apr;32(4):387-90.

PMID:2010737
Abstract

BACKGROUND

Controversy about fluid therapy in resuscitation has existed since the 1960s. The difficulty could be that fluid behavior at the lung capillary membrane level may vary depending on the patient's particular pathology.

METHODS

Mortality rates taken from randomized controlled trials were analyzed to compare colloidal and crystalloidal fluid for resuscitation efforts. We controlled for the underlying pathological process by categorizing subjects into three groups: (1) surgical stress, (2) hypovolemia, and (3) severe pulmonary failure. A cost-effectiveness analysis also was performed.

RESULTS

No statistically significant differences in mortality rates were found. The cost of each life saved using crystalloids is $45.13, and the cost of each life saved using colloidal solutions is $1493.60.

CONCLUSIONS

Because there is no significant mortality-rate advantage to using colloids, and because the cost-effectiveness ratio for crystalloids is much lower than for colloids, it is concluded that crystalloids should always be used in resuscitation efforts.

摘要

背景

自20世纪60年代以来,关于复苏中液体疗法的争议就一直存在。困难可能在于肺毛细血管膜水平的液体行为可能因患者的特定病理情况而异。

方法

分析来自随机对照试验的死亡率,以比较胶体液和晶体液用于复苏的效果。我们通过将受试者分为三组来控制潜在的病理过程:(1)手术应激,(2)血容量不足,和(3)严重肺衰竭。还进行了成本效益分析。

结果

未发现死亡率有统计学上的显著差异。使用晶体液挽救每条生命的成本为45.13美元,使用胶体液挽救每条生命的成本为1493.60美元。

结论

由于使用胶体液在死亡率方面没有显著优势,且晶体液的成本效益比远低于胶体液,因此得出结论,在复苏过程中应始终使用晶体液。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验